Screener
Nektar Therapeutics NKTR Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Nektar Therapeutics’s 10-Q, filed May 8, 2026.
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-212596
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $149,578 | $15,116 |
| Short-term investments | 419,026 | 230,636 |
| Other current assets (including $432 and $429 as of March 31, 2026 and December 31, 2025, respectively, from a related party) | 20,437 | 20,514 |
| Total current assets | 589,041 | 266,266 |
| Long-term investments | 162,993 | — |
| Other assets | 11,237 | 14,140 |
| Total assets | $763,271 | $280,406 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY |
Item 1. Condensed Consolidated Financial Statements—Unaudited:
FAQ
- What is Nektar Therapeutics's total current assets?
- Nektar Therapeutics (NKTR) reported total current assets of $589.04M in Q1 2026.
- How has Nektar Therapeutics's total current assets changed year-over-year?
- Nektar Therapeutics's total current assets increased by 156.2% year-over-year, from $229.91M to $589.04M.
- What is the long-term trend for Nektar Therapeutics's total current assets?
- Over 5 years (2020 to 2025), Nektar Therapeutics's total current assets has grown at a -25.2% compound annual growth rate (CAGR), from $1.14B to $266.27M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Nektar Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude